Additional Study. If within [***] after the JPC meeting at which a particular Proposed Study is discussed (or such longer period of time as agreed upon in writing by the Parties) (i) the other Party notifies the proposing Party in writing that the other Party wishes to cooperate in such Proposed Study, and any Related Studies contemplated at such time, on the terms (including design, budget and timeline) proposed by the proposing Party or (ii) the Parties agree in writing upon the terms (including design, budget, timeline and rights and obligations upon wind-down or [***]: CONFIDENTIAL PORTIONS OMITTED AND FILED SEPARATELY WITH THE COMMISSION. termination) under which they will cooperate in such Proposed Study, then it will be deemed an “Additional Study.” If such Additional Study is proposed by Mundipharma, the Development Plan shall be amended pursuant to Section 4.2(c) to include such Additional Study. The Parties shall have the diligence obligations with respect to such Additional Study as provided in Section 4.2(d). The Parties shall share all Joint Development Costs incurred to conduct such Additional Study in accordance with the applicable budget and in the proportions mutually agreed by the Parties. All Information resulting from such Additional Study will be available for use by each Party with respect to the Development and Commercialization of the Product in the Field in its respective territory in accordance with the licenses and rights granted or retained under Article 2 of this Agreement.